Emcure Pharmaceuticals Limited
EMCURE

Emcure Pharmaceuticals Limited

Pharmaceuticals
Share price
₹2,338
Market cap
₹44,317 Cr
1Y return
▲ 72%

A global pharmaceutical manufacturer established in 1981, Emcure Pharmaceuticals produces and markets a comprehensive range of drug formulations across multiple therapeutic areas for domestic and international markets. The company operates manufacturing facilities that serve patients globally, focusing on both generic and specialty pharmaceutical products. Emcure's diversified operations and geographic presence establish it as a significant player in the pharmaceutical industry.

Investors holding Emcure Pharmaceuticals Limited

Recent moves 15

Moves15
Government Pension Fund Global (Norway)New position
Government Pension Fund Global (Norway) now holds 20,00,000 shares of Emcure Pharmaceuticals, representing a 1.05% stake, up from under 1% in the prior update.
19 Oct 2026
Read more
Kotak Mutual FundNew position
Kotak Mutual Fund added over 1.31% of the company in the quarter and now holds 2.31%, or 43,81,625 shares.
19 Oct 2026
Read more
Nippon India Mutual FundDecreased
Nippon India Mutual Fund trimmed its stake in Emcure Pharmaceuticals from 1.95% to 1.19%, selling 14,36,943 shares.
19 Oct 2026
Read more
Aditya Birla Sun Life Mutual FundIncreased
Aditya Birla Sun Life Mutual Fund raised its stake in Emcure Pharmaceuticals from 1.31% to 1.45% by acquiring 2,56,640 shares.
19 Oct 2026
Read more
Morgan StanleyNew position
Morgan Stanley bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1817.00 apiece in a block deal. This transaction occurred on June 25, 2026.
25 Jun 2026
Read more
HSBC Mutual FundNew position
HSBC Mutual Fund bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1,817.00 apiece in a block deal.
25 Jun 2026
Read more
HDFC Life InsuranceNew position
HDFC Life Insurance bought 5,56,954 shares of Emcure Pharmaceuticals for ₹101.20 Cr at ₹1817.00 apiece in a block deal.
25 Jun 2026
Read more
Goldman SachsNew position
Goldman Sachs bought 1,37,590 shares of Emcure Pharmaceuticals Limited for ₹25.00 Cr at ₹1817.00 apiece in a block deal.
25 Jun 2026
Read more
BNP ParibasNew position
BNP Paribas bought 137,592 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1817.00 apiece in a block deal.
25 Jun 2026
Read more
Axis Mutual FundNew position
Axis Mutual Fund bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1817.00 apiece in a block deal.
25 Jun 2026
Read more

Track the whales in Emcure Pharmaceuticals Limited

Get alerted the moment a top investor buys or sells.

Start 7 days for ₹1